Genome-wide Association Analyses Define Pathogenic Signaling Pathways and Prioritize Drug Targets for IgA Nephropathy

IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751 controls across 17 international cohorts. We defined 30 genome-wide significant risk loci explaining 11% of disease risk. A total of 16 loci were new, including TNFSF4/TNFSF18, REL, CD28, PF4V1, LY86, LYN, ANXA3, TNFSF8/TNFSF15, REEP3, ZMIZ1, OVOL1/RELA, ETS1, IGH, IRF8, TNFRSF13B and FCAR. The risk loci were enriched in gene orthologs causing abnormal IgA levels when genetically manipulated in mice. We also observed a positive genetic correlation between IgAN and serum IgA levels. High polygenic score for IgAN was associated with earlier onset of kidney failure. In a comprehensive functional annotation analysis of candidate causal genes, we observed convergence of biological candidates on a common set of inflammatory signaling pathways and cytokine ligand-receptor pairs, prioritizing potential new drug targets.

Citing Articles

Targeted-release budesonide: A comprehensive review on its potential in IgA nephropathy.

Qi F, Zeng H, Zhang J Heliyon. 2025; 11(4):e42729.

PMID: 40061933 PMC: 11889547. DOI: 10.1016/j.heliyon.2025.e42729.

Expected and verified benefits from old and new corticosteroid treatments in IgA nephropathy: from trials in adults to new IPNA-KDIGO guidelines.

Peruzzi L, Coppo R Pediatr Nephrol. 2025; .

PMID: 40042624 DOI: 10.1007/s00467-025-06725-1.

Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity.

Nurmi M, Perez-Alos L, Garred P, Fellstrom B, Gabrysch K, Lundberg S Clin Kidney J. 2025; 18(1):sfae395.

PMID: 40008348 PMC: 11852328. DOI: 10.1093/ckj/sfae395.

Single-Cell RNA-Sequencing Analysis Provides Insights into IgA Nephropathy.

Xia M, Li Y, Liu Y, Dong Z, Liu H Biomolecules. 2025; 15(2).

PMID: 40001494 PMC: 11853383. DOI: 10.3390/biom15020191.

The road ahead: emerging therapies for primary IgA nephropathy.

Filippone E, Gulati R, Farber J Front Nephrol. 2025; 5:1545329.

PMID: 39968279 PMC: 11832374. DOI: 10.3389/fneph.2025.1545329.

References

Suhre K, Shin S, Petersen A, Mohney R, Meredith D, Wagele B . Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011; 477(7362):54-60. PMC: 3832838. DOI: 10.1038/nature10354. View

Eppig J, Blake J, Bult C, Kadin J, Richardson J . The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease. Nucleic Acids Res. 2014; 43(Database issue):D726-36. PMC: 4384027. DOI: 10.1093/nar/gku967. View

Gharavi A, Kiryluk K, Choi M, Li Y, Hou P, Xie J . Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet. 2011; 43(4):321-7. PMC: 3412515. DOI: 10.1038/ng.787. View

Suhre K, Arnold M, Mukund Bhagwat A, Cotton R, Engelke R, Raffler J . Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun. 2017; 8:14357. PMC: 5333359. DOI: 10.1038/ncomms14357. View

Mountjoy E, Schmidt E, Carmona M, Schwartzentruber J, Peat G, Miranda A . An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nat Genet. 2021; 53(11):1527-1533. PMC: 7611956. DOI: 10.1038/s41588-021-00945-5. View

Zhou H, Schmidt S, Jiang S, Willox B, Bernhardt K, Liang J . Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe. 2015; 17(2):205-16. PMC: 4539236. DOI: 10.1016/j.chom.2014.12.013. View

Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T . GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford). 2017; 2017. PMC: 5467550. DOI: 10.1093/database/bax028. View

Schmiedel B, Singh D, Madrigal A, Valdovino-Gonzalez A, White B, Zapardiel-Gonzalo J . Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression. Cell. 2018; 175(6):1701-1715.e16. PMC: 6289654. DOI: 10.1016/j.cell.2018.10.022. View

Gorski M, van der Most P, Teumer A, Chu A, Li M, Mijatovic V . 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function. Sci Rep. 2017; 7:45040. PMC: 5408227. DOI: 10.1038/srep45040. View

10.

Titze S, Schmid M, Kottgen A, Busch M, Floege J, Wanner C . Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol Dial Transplant. 2014; 30(3):441-51. DOI: 10.1093/ndt/gfu294. View

11.

de Leeuw C, Mooij J, Heskes T, Posthuma D . MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015; 11(4):e1004219. PMC: 4401657. DOI: 10.1371/journal.pcbi.1004219. View

12.

Infante B, Rossini M, Di Lorenzo A, Coviello N, Giuseppe C, Gesualdo L . Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy. Clin Kidney J. 2020; 13(5):758-767. PMC: 7577761. DOI: 10.1093/ckj/sfaa060. View

13.

Abecasis G, Auton A, Brooks L, DePristo M, Durbin R, Handsaker R . An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491(7422):56-65. PMC: 3498066. DOI: 10.1038/nature11632. View

14.

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M . Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014; 46(11):1187-96. PMC: 4213311. DOI: 10.1038/ng.3118. View

15.

Shin S, Fauman E, Petersen A, Krumsiek J, Santos R, Huang J . An atlas of genetic influences on human blood metabolites. Nat Genet. 2014; 46(6):543-550. PMC: 4064254. DOI: 10.1038/ng.2982. View

16.

Sun B, Maranville J, Peters J, Stacey D, Staley J, Blackshaw J . Genomic atlas of the human plasma proteome. Nature. 2018; 558(7708):73-79. PMC: 6697541. DOI: 10.1038/s41586-018-0175-2. View

17.

Feriozzi S, Polci R . The role of tonsillectomy in IgA nephropathy. J Nephrol. 2015; 29(1):13-9. DOI: 10.1007/s40620-015-0247-4. View

18.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

19.

Li M, Foo J, Wang J, Low H, Tang X, Toh K . Identification of new susceptibility loci for IgA nephropathy in Han Chinese. Nat Commun. 2015; 6:7270. PMC: 4458882. DOI: 10.1038/ncomms8270. View

20.

Shi J, Lee S . A novel random effect model for GWAS meta-analysis and its application to trans-ethnic meta-analysis. Biometrics. 2016; 72(3):945-54. PMC: 4996751. DOI: 10.1111/biom.12481. View